eMedicine Specialties > Dermatology > Environmental

Black Heel (Calcaneal Petechiae): Follow-up

Author: Christine Malcolm, MD, Resident Physician in Dermatology, Department of Internal Medicine, University of Toronto Faculty of Medicine
Coauthor(s): Joel G DeKoven, MD, FRCPC, Associate Professor, Division of Dermatology, Department of Medicine, University of Toronto, Sunnybrook Health Sciences Centre and St Michael's Hospital, Canada; Scott Richard Albert Walsh, MD, PhD, Assistant Professor, Program Director, Department of Dermatology, University of Toronto, Sunnybrook Health Sciences Centre
Contributor Information and Disclosures

Updated: Sep 23, 2009

Follow-up

Prognosis

  • Prognosis for black heel (calcaneal petechiae) is excellent. Complete clearing is achieved with cessation of the causative activity usually within 2-3 weeks of rest.

Miscellaneous

Medicolegal Pitfalls

  • The only medicolegal pitfall in management of black heel (calcaneal petechiae) is the failure to diagnose an acral melanoma, which may appear as a black spot on the heel. If melanoma is a realistic diagnostic consideration, a skin biopsy is indicated.
 
Acknowledgments

The authors and editors of eMedicine gratefully acknowledge the contributions of previous authors, Jonathan Baron, MD, and Norman Levine, MD, and previous Chief Editor, William D. James, MD, to the development and writing of this article.



More on Black Heel (Calcaneal Petechiae)

Overview: Black Heel (Calcaneal Petechiae)
Differential Diagnoses & Workup: Black Heel (Calcaneal Petechiae)
Treatment & Medication: Black Heel (Calcaneal Petechiae)
Follow-up: Black Heel (Calcaneal Petechiae)
Multimedia: Black Heel (Calcaneal Petechiae)
References
[ CLOSE WINDOW ]

References

  1. Crissey JT, Peachy JC. Calcaneal petechiae. Arch Dermatol. Mar 1961;83:501. [Medline].

  2. Rufli T. Hyperkeratosis haemorrhagica. Hautarzt. Nov 1980;31(11):606-9. [Medline].

  3. Mailler-Savage EA, Adams BB. Skin manifestations of running. J Am Acad Dermatol. Aug 2006;55(2):290-301. [Medline].

  4. Akasu R, Sugiyama H, Araki M, Ohtake N, Furue M, Tamaki K. Dermatoscopic and videomicroscopic features of melanocytic plantar nevi. Am J Dermatopathol. Feb 1996;18(1):10-8. [Medline].

  5. Saida T, Oguchi S, Ishihara Y. In vivo observation of magnified features of pigmented lesions on volar skin using video macroscope. Usefulness of epiluminescence techniques in clinical diagnosis. Arch Dermatol. Mar 1995;131(3):298-304. [Medline].

  6. Malvehy J, Puig S, Braun RP, Marghoob AA, Kopf AW. Handbook of Dermoscopy. United Kingdom: Informa UK Ltd; 2006:70.

  7. Elder DE. Lever's Histopathology of the Skin. 9th ed. Lippincott Williams & Wilkins; 2005:367.

  8. Hafner J, Haenseler E, Ossent P, Burg G, Panizzon RG. Benzidine stain for the histochemical detection of hemoglobin in splinter hemorrhage (subungual hematoma) and black heel. Am J Dermatopathol. Aug 1995;17(4):362-7. [Medline].

  9. Weedon D. Skin Pathology. 2nd ed. Elsevier Limited; 2002:595.

  10. Adams BB. Dermatologic disorders of the athlete. Sports Med. 2002;32(5):309-21. [Medline].

  11. Cho KH, Kim YG, Seo KI, Suh DH. Black heel with atypical melanocytic hyperplasia. Clin Exp Dermatol. Sep 1993;18(5):437-40. [Medline].

  12. Garcia-Doval I, de la Torre C, Losada A, Cruces MJ. Disseminated punctate intraepidermal haemorrhage: a widespread counterpart of black heel. Acta Derm Venereol. Sep 1999;79(5):403. [Medline].

  13. Levine N. Dermatologic aspects of sports medicine. J Am Acad Dermatol. Oct 1980;3(4):415-24. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

black heel, calcaneal petechiae, talon noir, tennis heel, hyperkeratosis haemorrhagica, pseudochromhidrosis plantaris

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Christine Malcolm, MD, Resident Physician in Dermatology, Department of Internal Medicine, University of Toronto Faculty of Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Joel G DeKoven, MD, FRCPC, Associate Professor, Division of Dermatology, Department of Medicine, University of Toronto, Sunnybrook Health Sciences Centre and St Michael's Hospital, Canada
Joel G DeKoven, MD, FRCPC is a member of the following medical societies: American Academy of Dermatology, American Contact Dermatitis Society, Canadian Medical Association, and Royal College of Physicians and Surgeons of Canada
Disclosure: Nothing to disclose.

Scott Richard Albert Walsh, MD, PhD, Assistant Professor, Program Director, Department of Dermatology, University of Toronto, Sunnybrook Health Sciences Centre
Scott Richard Albert Walsh, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, Canadian Dermatology Association, International Society of Dermatology, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

Medical Editor

Donald Belsito, MD, Clinical Professor, Department of Internal Medicine, Division of Dermatology, University of Missouri at Kansas City; Private Practice, American Dermatology Associates, LLC
Donald Belsito, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Contact Dermatitis Society, Dermatology Foundation, Kansas Medical Society, Noah Worcester Dermatological Society, Phi Beta Kappa, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Pharmacy Editor

David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Managing Editor

Edward F Chan, MD, Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania School of Medicine
Edward F Chan, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.